Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib.
- Author:
Yi-Sheng HUANG
1
;
Biao HUANG
;
Yi-Long WU
Author Information
1. Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China.
- Publication Type:Case Reports
- MeSH:
Carcinoma, Non-Small-Cell Lung;
drug therapy;
Female;
Humans;
Leukoencephalopathies;
chemically induced;
diagnosis;
Lung Neoplasms;
drug therapy;
Middle Aged;
Quinazolines;
adverse effects;
therapeutic use
- From:
Chinese Medical Journal
2011;124(22):3834-3837
- CountryChina
- Language:English
-
Abstract:
The present case is a patient with advanced non-small cell lung cancer (NSCLC) who developed leukoencephalopathy following radiotherapy and gefitinib treatments. There are rarely reports of such incidences because the median survival period of advanced NSCLC is only ten months. The features of leukoencephalopathy in this case were atypical for radiation leukoencephalopathy, so it was suspected that the leukoencephalopathy was associated with gefitinib.
